248 related articles for article (PubMed ID: 16344467)
1. Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A.
Ho JG; Greco A; Rupnik M; Ng KK
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18373-8. PubMed ID: 16344467
[TBL] [Abstract][Full Text] [Related]
2. Use of a neutralizing antibody helps identify structural features critical for binding of
Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
[No Abstract] [Full Text] [Related]
3. Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography.
Orth P; Xiao L; Hernandez LD; Reichert P; Sheth PR; Beaumont M; Yang X; Murgolo N; Ermakov G; DiNunzio E; Racine F; Karczewski J; Secore S; Ingram RN; Mayhood T; Strickland C; Therien AG
J Biol Chem; 2014 Jun; 289(26):18008-21. PubMed ID: 24821719
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for antibody recognition in the receptor-binding domains of toxins A and B from Clostridium difficile.
Murase T; Eugenio L; Schorr M; Hussack G; Tanha J; Kitova EN; Klassen JS; Ng KK
J Biol Chem; 2014 Jan; 289(4):2331-43. PubMed ID: 24311789
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A.
Huang JH; Shen ZQ; Lien SP; Hsiao KN; Leng CH; Chen CC; Siu LK; Chong PC
PLoS One; 2015; 10(8):e0135045. PubMed ID: 26271033
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate recognition by Clostridium difficile toxin A.
Greco A; Ho JG; Lin SJ; Palcic MM; Rupnik M; Ng KK
Nat Struct Mol Biol; 2006 May; 13(5):460-1. PubMed ID: 16622409
[TBL] [Abstract][Full Text] [Related]
7. Phylogenomics of 8,839 Clostridioides difficile genomes reveals recombination-driven evolution and diversification of toxin A and B.
Mansfield MJ; Tremblay BJ; Zeng J; Wei X; Hodgins H; Worley J; Bry L; Dong M; Doxey AC
PLoS Pathog; 2020 Dec; 16(12):e1009181. PubMed ID: 33370413
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning, overexpression in Escherichia coli, and purification of 6x his-tagged C-terminal domain of Clostridium difficile toxins A and B.
Letourneur O; Ottone S; Delauzun V; Bastide MC; Foussadier A
Protein Expr Purif; 2003 Oct; 31(2):276-85. PubMed ID: 14550648
[TBL] [Abstract][Full Text] [Related]
9. The C-Terminal Domain of Clostridioides difficile TcdC Is Exposed on the Bacterial Cell Surface.
Oliveira Paiva AM; de Jong L; Friggen AH; Smits WK; Corver J
J Bacteriol; 2020 Oct; 202(22):. PubMed ID: 32868401
[No Abstract] [Full Text] [Related]
10. Sulfated glycosaminoglycans and low-density lipoprotein receptor contribute to Clostridium difficile toxin A entry into cells.
Tao L; Tian S; Zhang J; Liu Z; Robinson-McCarthy L; Miyashita SI; Breault DT; Gerhard R; Oottamasathien S; Whelan SPJ; Dong M
Nat Microbiol; 2019 Oct; 4(10):1760-1769. PubMed ID: 31160825
[TBL] [Abstract][Full Text] [Related]
11. Four distinct structural domains in Clostridium difficile toxin B visualized using SAXS.
Albesa-Jové D; Bertrand T; Carpenter EP; Swain GV; Lim J; Zhang J; Haire LF; Vasisht N; Braun V; Lange A; von Eichel-Streiber C; Svergun DI; Fairweather NF; Brown KA
J Mol Biol; 2010 Mar; 396(5):1260-70. PubMed ID: 20070948
[TBL] [Abstract][Full Text] [Related]
12. Toward a structural understanding of Clostridium difficile toxins A and B.
Pruitt RN; Lacy DB
Front Cell Infect Microbiol; 2012; 2():28. PubMed ID: 22919620
[TBL] [Abstract][Full Text] [Related]
13. A neutralizing antibody that blocks delivery of the enzymatic cargo of
Kroh HK; Chandrasekaran R; Zhang Z; Rosenthal K; Woods R; Jin X; Nyborg AC; Rainey GJ; Warrener P; Melnyk RA; Spiller BW; Lacy DB
J Biol Chem; 2018 Jan; 293(3):941-952. PubMed ID: 29180448
[No Abstract] [Full Text] [Related]
14. Crystal structure of Clostridium difficile toxin A.
Chumbler NM; Rutherford SA; Zhang Z; Farrow MA; Lisher JP; Farquhar E; Giedroc DP; Spiller BW; Melnyk RA; Lacy DB
Nat Microbiol; 2016 Jan; 1():15002. PubMed ID: 27571750
[TBL] [Abstract][Full Text] [Related]
15. Identification of a hemorrhagic determinant in
Zheng Y; Yang Q; Luo J; Zhang Y; Li X; He L; Ma C; Tao L
Microbiol Spectr; 2024 Jun; 12(6):e0035424. PubMed ID: 38709085
[No Abstract] [Full Text] [Related]
16. The Importance of Therapeutically Targeting the Binary Toxin from
Abeyawardhane DL; Godoy-Ruiz R; Adipietro KA; Varney KM; Rustandi RR; Pozharski E; Weber DJ
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805767
[TBL] [Abstract][Full Text] [Related]
17. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.
Pruitt RN; Chumbler NM; Rutherford SA; Farrow MA; Friedman DB; Spiller B; Lacy DB
J Biol Chem; 2012 Mar; 287(11):8013-20. PubMed ID: 22267739
[TBL] [Abstract][Full Text] [Related]
18. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function.
Jank T; Giesemann T; Aktories K
Glycobiology; 2007 Apr; 17(4):15R-22R. PubMed ID: 17237138
[TBL] [Abstract][Full Text] [Related]
19. Sequencing and analysis of the gene encoding the alpha-toxin of Clostridium novyi proves its homology to toxins A and B of Clostridium difficile.
Hofmann F; Herrmann A; Habermann E; von Eichel-Streiber C
Mol Gen Genet; 1995 Jun; 247(6):670-9. PubMed ID: 7616958
[TBL] [Abstract][Full Text] [Related]
20. Structure of the cell-binding component of the
Xu X; Godoy-Ruiz R; Adipietro KA; Peralta C; Ben-Hail D; Varney KM; Cook ME; Roth BM; Wilder PT; Cleveland T; Grishaev A; Neu HM; Michel SLJ; Yu W; Beckett D; Rustandi RR; Lancaster C; Loughney JW; Kristopeit A; Christanti S; Olson JW; MacKerell AD; Georges AD; Pozharski E; Weber DJ
Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1049-1058. PubMed ID: 31896582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]